Comparative analysis of new drug research and development strategy of representative enterprises in the field of diabetes mellitus based on patent perspective
LIU Pei-ran
CONG Jun-jie
MENG Qing-hai
Abstract：The development of antidiabetic drug is the most intense competition field of biopharmaceutical industries,and Novo Nordisk and Sanofi Aventis are the leader companies in the international market competition,so their development mode and development strategy have a strong representation.In this paper,the patents of antidiabetic drug from Thomson Innovation (TI) patent database were collected and analyzed,and the annual and regional distribution,the main collaborators and the inventors of the patents in this field from Novo Nordisk and Sanofi Aventis were discussed.In addition,a useful reference for the development of Chinese biopharmaceutical enterprises can be provided through the discussion of their development directions and development strategies.
Keywords：diabetesnew drug researchpatententerprisecomparative analysis
Publication Date：2017-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 494-498 )